The poster presented at the meeting will be made available on the Glucotrack website following the conference.

Shares of Incyte (NASDAQ:INCY) climbed 7% today after the biopharmaceutical company announced that multiple presentations, including new late-breaking data for its monoclonal antibody INCA033989, have ...

Several AON physicians and leaders shared new cancer research at one of oncology’s most influential gatheringsFORT MYERS, Fla ...

Incyte Corporation (NASDAQ:INCY) saw its stock surge 7% after the company announced that multiple research presentations, ...

Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced ...

Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs ...

Orthopaedic surgery resident Thomas Listopadzki, MD ’22, has received the award for “Best Adult Reconstruction Hip Poster” at the 2025 American Academy of Orthopaedic Surgeons (AAOS) conference this ...

IMNN READ THE FULL IMNN RESEARCH REPORT Business Update Momentum Continues with Presentations at ASCO and ESMO Imunon, Inc.

Context Therapeutics Inc. (“Context” or “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging (“TCE”) bispecific antibodies for solid tumors, announced today ...

Multiple Subgroup Analyses Presented From Long-Term Safety Study of LYBALVI® (olanzapine and samidorphan), Including Data on Lipid an ...

Three BriaCell posters and one publish-only abstract highlight robust clinical data from Bria-IMT™ and Bria-OTS™ studies in metastatic breast cancer (MBC) Median Overall Survival of 17.3 months in ...

An colon cancer study highlighted the importance of the National Cancer Institute, while cancer doctors got a look at a bispecific antibody newly licensed by Pfizer.